Drug profile · INN
novobiocin sodium
ALBAMYCIN
novobiocin sodium (ALBAMYCIN) is a dna gyrase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — novobiocin sodium
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
novobiocin sodium (ALBAMYCIN) is a dna gyrase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
DNA gyrase inhibitor
Primary target: DNA gyrase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is novobiocin sodium?
novobiocin sodium (ALBAMYCIN) is a dna gyrase inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for novobiocin sodium?
ALBAMYCIN is a marketed brand name for novobiocin sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of novobiocin sodium?
novobiocin sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.